Human Cannabinoid Receptor Interacting Protein 1 (CNRIP1) Protein
Pida mas información
935106861
info@markelab.com
Precio
221€ (10 µg)
Protein CNRIP1
proveedor
Abbexareference
abx650577Tested Applications
WB, SDS-PAGEreactivity
status
RUOclonality
Descripción
Human CNRIP1 Protein is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).
Background
Cannabinoid receptor interacting protein 1 (CNRIP1) is an intracellular protein that interacts with cannabinoid receptors, specifically CB1 (cannabinoid receptor type 1), which is primarily found in the central nervous system and plays a pivotal role in modulating various physiological processes, including pain perception, appetite, and mood. CNRIP1 is thought to be involved in regulating the signaling pathways of CB1, modulating its activity, and potentially impacting receptor desensitization or internalization. Through its interaction with CB1, CNRIP1 indirectly participates in the endocannabinoid system, which maintains homeostasis in processes such as synaptic transmission, immune response, and neuroprotection. Beyond the nervous system, CNRIP1 may also influence metabolic and energy balance functions, as CB1 receptors are expressed in peripheral tissues like adipose tissue, liver, and skeletal muscle. Aberrant expression or function of CNRIP1 has been implicated in pathological conditions such as obesity, neurodegenerative disorders, and substance use disorders, highlighting its potential as a target for therapeutic interventions. CNRIP1 continues to be an area of active research, with a focus on elucidating its precise molecular mechanisms and broader implications in cannabinoid receptor-mediated pathways.
Características del producto
category
Proteins and Peptides
origin
Human
host
E. coli
immunogen target
Cannabinoid Receptor Interacting Protein 1 (CNRIP1)
host
E. coli
conjugation
Unconjugated
form
Lyophilized To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
tested applications
WB, SDS-PAGE
size 1
10 µg
size 2
50 µg
size 3
100 µg
size 4
200 µg
size 5
500 µg
observerd MW
Molecular Weight: Calculated MW: 18.7 kDa Concentration: Prior to lyophilization: 200 µg/ml Sequence Fragment: Gln34-Leu164 Tag: N-terminal His tag
expression
Recombinant
purity
> 95%
buffer
Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
storage
Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
or code
CNRIP1
dry ice
No
availability
Shipped within 5-7 working days.
alias
CNRIP1,CRIP1,CRIP-1,C2orf32
uniprot id
note
This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.
Quizá le pueda interesar
anti- CNRIP1 antibody
proveedor
FineTestreference
FNab01818Tested Applications
ELISA, WB, IHCreactivity
human,mouse,ratstatus
RUOclonality
polyclonalIsoform 1 suppresses cannabinoid receptor CNR1-mediated tonic inhibition of voltage-gated calcium channels. Isoform 2 do...
Precio a consultar
Ver másRecombinant Human CNRIP1
proveedor
FineTestreference
P6410Tested Applications
Western Blot，ELISAstatus
RUOPrecio a consultar
Ver másCB1 Cannabinoid Receptor-Interacting Protein 1 (CNRP1) Antibody
proveedor
Abbexareference
abx026959Tested Applications
ELISA, WB, IHCreactivity
Humanstatus
RUOclonality
PolyclonalThis gene encodes a G-protein coupled receptor which interacts with the C-terminal tail of cannabinoid receptor 1. This ...
292.5€ (80 µl)
Ver más